A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study first-stage.

Authors

Stefano Tamberi

Ospedale per Gli Infermi, Faenza, Italy

Stefano Tamberi , Elisa Grassi , Jody Corbelli , Giorgio Papiani , Maria aurelia Barbera , Chiara Zingaretti , Chiara Carli Moretti , Isacco Montroni , Elisabetta Petracci , Dora Caruso , Sofia Nosseir , Oriana Nanni , Giovanni Luca Frassineti , Maria Di Bartolomeo , Marina Marzola , Andrea Bonetti , Fabio Gelsomino , Carmine Pinto , Davide Tassinari , Giampaolo Ugolini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT04083365

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3607)

DOI

10.1200/JCO.2021.39.15_suppl.3607

Abstract #

3607

Poster Bd #

Online Only

Abstract Disclosures

FEATURED

A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study first-stage.

Authors

Stefano Tamberi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.